Pfizer Grows In Rare Disease With $810m Dwarfism Company Buy

 
• By Jo Shorthouse
  
Black swan
Pfizer adds asset in rare diseases • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip